26 samples
Export
<<< of 2>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterXiaosheng Tan Remove filterJun 07, 2023
GSM6685565
in vitro, control splenic CD4+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685566
in vitro, control splenic CD4+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685567
in vitro, lycorine treated splenic CD4+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685568
in vitro, lycorine treated splenic CD4+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685569
in vitro, control CD4+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685570
in vitro, control CD4+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685571
in vitro, control CD4+ T, 3
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685572
in vitro, control CD4+ T, 4
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685573
in vitro, lycorine treated CD4+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685574
in vitro, lycorine treated CD4+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685575
in vitro, lycorine treated CD4+ T, 3
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685576
in vitro, lycorine treated CD4+ T, 4
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685577
in vitro, control CD8+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685578
in vitro, control CD8+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685579
in vitro, control CD8+ T, 3
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685580
in vitro, control CD8+ T, 4
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685581
in vitro, lycorine treated CD8+ T, 1
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685582
in vitro, lycorine treated CD8+ T, 2
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685583
in vitro, lycorine treated CD8+ T, 3
 SRA 1 Xiaosheng Tan Jun 07, 2023
GSM6685584
in vitro, lycorine treated CD8+ T, 4
 SRA 1 Xiaosheng Tan Jun 07, 2023